Rotasiil-Liquid Description

Each dose of 2 ml contains: Live Attenuated Bovine-Human Rotavirus Reassortant [G1, G2, G3, G4 and G9]* ≥10^5.6 FFU/Serotype.
*Grown on vero cells.
ROTASIIL-Liquid [Rotavirus Vaccine, Live Attenuated (Oral)] supplied by Serum Institute of India Pvt. Ltd. is a Liquid Bovine Human Reassortant Rotavirus-Pentavalent Vaccine (LBRV-PV). The vaccine constitutes five viruses (Human and Bovine reassortant strains) of serotype G1, G2, G3, G4, and G9. All these strains constitute VP7 gene of respective serotype from human strains reassorted with bovine (UK) rotavirus. Each strain is propagated in VERO cells individually; and all five strains are blended before filling.
ROTASIIL-Liquid is available as ready to use liquid formulation and the product has the appearance of yellowish translucent liquid with possible presence of inherent product aggregates. The vaccine contains no preservatives. ROTASIIL-Liquid is for oral administration and not for injection. The vaccine conforms to I.P. and World Health Organization (W.H.O.) requirements.
Dose: 2 ml - 1 dose by oral administration.
Excipients/Inactive Ingredients: Citric Acid Anhydrous, Potassium Phosphate Dibasic Anhydrous, Sucrose, Hydrolyzed Gelatin, Zinc Chloride, Calcium Chloride Dihydrate, Sodium citrate tribasic dihydrate, Eagle's MEM (Minimum Essential Medium) with Hank's Salts, Glutamine, Sodium Bicarbonate and Water for injection.
This vaccine contains no Preservatives.